Monitoring Treatment Response
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Monitoring Treatment Response
-
Letto da:
-
Di:
Kari Magee speaks with Dr Bethany Verkamp to discuss her research on evaluating treatment response to etoposide-based treatment in patients with hemophagocytic lymphohistiocytosis (HLH). The discussion covers clinical and laboratory considerations for monitoring HLH treatment response, including how clinicians may evaluate response over time while managing HLH in patients.
This video features expert clinician discussion and is intended for US healthcare professionals.
Chapters
0:00 - Monitoring Hemophagocytic Lymphohistiocytosis (HLH) Treatment Response: Study Context
2:07 - Study Design: Evaluating HLH Treatment Response
9:19 - Clinical and Laboratory Response Findings in HLH
11:37 - How HCPs May Monitor Treatment Response in HLH
13:53 - Key Takeaways for HLH Response Monitoring
Follow Us
- YouTube @Sobi-Pharma
- Linkedin @Sobi
Presented by Sobi Inc.
https://www.sobi.com/usa/en
©2023 Sobi, Inc. All rights reserved. NP-32204 12/23
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.